CIRM Awards $28 Million to Answer Fundamental Questions in Stem Cell Biology
Los Angeles, Calif., April 29, 2010 – At a meeting at the City of Hope, the governing board of the California Institute for Regenerative Medicine, the state stem cell agency created by Proposition 71, approved funding $28 million to support 16 Basic Biology II Awards that answer fundamental questions about stem cell biology and one Leadership Award.
The Basic Biology II Awards went to nine non-profit and one for-profit institutions, building on the 12 Basic Biology awards given out in 2009. These awards form the foundation for future translational and clinical advances, enabling the realization of the full potential of human stem cells and reprogrammed cells for therapies and as tools for biomedical innovation.
“Understanding the fundamental questions in stem cell biology and the development of innovative approaches to their differentiation is essential for realizing that goal and bringing new stem cell therapies to patients,” said Alan Trounson, CIRM President. “We expect many of these outstanding projects will provide the next platform for application in regenerative medicine and to provide answers that remove road blocks to projects that are already close to the clinic.”
The Leadership Awards aid in recruiting early to mid-career stem cell scientists to California institutions by permitting the recipients to pursue high-risk, high payoff, innovative studies that could not be adequately supported by other sources. This is the first cycle, which CIRM will repeat quarterly. The award went to Robert Wechsler-Reya, who would be moving his research in neural development and cancer stem cells from Duke University to the Sanford-Burnham Medical Research Institute in La Jolla. The candidate was given until the end of June to finalize negotiations with the institution.
“The national and international leaders in stem cell biology who we recruit with these Leadership awards will ensure that California has the expertise needed to drive the creation of innovative therapies for patients suffering from a chronic disease or injury,” said Robert Klein, chair of the CIRM Governing Board. “Bringing this caliber of scientist to California also creates high paying positions to staff the labs, providing new jobs and tax revenue to the state.
Additional ICOC Business
The board also voted on formal positions regarding three bills that are in various stages of the legislative process in Sacramento.
- The board endorsed AB 1931, introduced by assembly majority leader Alberto Torrico, which would extend the Roman Reed Spinal Cord Injury Research Act of 1999 through January of 2016. The act, which continuously appropriates funds for spinal cord injury research to the University of California, was schedule to expire on January 2011.
- The board endorsed AB 1733, introduced by assembly member Jerry Hill, which would create the Director of California Biotechnology Retention and Recruitment within the Governor’s office. The office is intended to foster collaboration between state government, universities and the private sector.
- The board gave permission to staff and its legislative subcommittee to negotiate modifications to SB 1064, introduced by Senator Elaine Alquist. The board backed specific provisions to raise the 50-person cap on CIRM staff and to increase the pay for patient advocate board members serving on the Grants Working Group.
Basic Biology II Awards
|PI Name||Institution||Total Budget|
|RB2-01571||Benhur Lee||University of California, Los Angeles||$1,371,936|
|RB2-01602||John Rubenstein||University of California, San Francisco||$1,387,800|
|RB2-01553||Aaron Hsueh||Stanford University||$1,432,197|
|RB2-01530||Ronald Evans||The Salk Institute for Biological Studies||$1,712,880|
|RB2-01497||Steven Artandi||Stanford University||$1,430,908|
|RB2-01502||Douglas Black||University of California, Los Angeles||$1,350,994|
|RB2-01628||Berta Strulovici||iPierian, Inc.||$1,458,000|
|RB2-01547||Kun-Liang Guan||University of California, San Diego||$1,340,565|
|RB2-01592||Garry Nolan||Stanford University||$1,447,956|
|RB2-01496||Aileen Anderson||University of California, Irvine||$1,284,921|
|RB2-01629||Marian Waterman||University of California, Irvine||$1,277,101|
|RB2-01637||Tony Wyss-Coray||Palo Alto Institute for Research and Education, Inc.||$1,522,800|
|RB2-01562||Yong Kim||University of California, Los Angeles||$1,259,371|
|RB2-01645||Dong-Er Zhang||University of California, San Diego||$1,371,540|
|RB2-01512||Huei-sheng Chen||Sanford-Burnham Medical Research Institute||$1,587,610|
|RB2-01567||Eric Kurzrock||University of California, Davis||$885,600|
Research Leadership Awards
|Application Number||PI Name||Institution||Total Budget|
|LA1-01747||Robert Wechsler-Reya||Sanford-Burnham Medical Research Institute||$5,919,616|
For a list of all institutions funded by CIRM, with funding levels, please visit: /our-funding/funded-institutions
About CIRM CIRM was established in November 2004 with the passage of Proposition 71, the California Stem Cell Research and Cures Act. The statewide ballot measure, which provided $3 billion in funding for stem cell research at California universities and research institutions, was overwhelmingly approved by voters, and called for the establishment of an entity to make grants and provide loans for stem cell research, research facilities, and other vital research opportunities. To date, the CIRM governing board has approved 345 research, training and facility grants totaling more than $1 billion, making CIRM the largest source of funding for human embryonic stem cell research in the world. Estimates suggest that these grants already awarded will generate tens of thousands of job-years of employment in the state.